Clinical Trial Update: Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

View source ↗

Summary

An observational real-world study examining the use of tildrakizumab in adults with moderate to severe plaque psoriasis in routine clinical practice. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Almirall, S.A. | Conditions: Plaque Psoriasis | Status: COMPLETED | Results posted: 2026-03-02